Clinical Trial Update: The Effect of MK0633 in Patients With Chronic Asthma (0633-007) [Phase 2]

View source ↗

Summary

Phase 2 trial of MK0633 in chronic asthma has been terminated; the report provides no efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0633

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: TERMINATED